>copaxone, avonex and tysabri are all growing at a healthy rate. Is the MS market expanding that much?<
Price and currency—rather than unit volume—account for a lot of the growth in dollar sales. The worldwide MS market is close to $9B, based on the latest figures.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”